Brown Advisory Mid-Cap Growth Fund Investor Class (BMIDX) - Mid-Cap Growth fund with $6.89 Million in assets. The fund allocates 22.64% of its portfolio to its top 10 holdings. It primarily invests in averagemarketcap cap stocks , with a focus on the cash and equivalents sector.
The largest holding in the fund is Dexcom Inc at 2.87% of total assets. This is followed by First American Government Obligations Fund (3.00%) and Marvell Technology Inc (2.63%).
| Name | Weight | Owned | Change |
|---|---|---|---|
| Dexcom Inc | 2.87% | - | - |
| First American Government Obligations Fund | 3.00% | - | - |
| Marvell Technology Inc | 2.63% | - | - |
| Waste Connections Inc | 3.03% | - | - |
| Cheniere Energy Inc | 2.64% | - | - |
| Copart Inc | None | - | - |
| CoStar Group Inc | 3.26% | - | - |
| Edwards Lifesciences Corp | None | - | - |
| Gartner Inc | 2.72% | - | - |
| Fair Isaac Corp | 2.49% | - | - |
| Equifax Inc | 2.74% | - | - |
| Verisk Analytics Inc | 2.48% | - | - |
| Insulet Corp | 2.62% | - | - |
| Veeva Systems Inc | 2.45% | - | - |
| West Pharmaceutical Services Inc | 3.53% | - | - |
| Arthur J Gallagher Co | 3.01% | - | - |
| HEICO Corp | 2.62% | - | - |
| Tradeweb Markets Inc | 2.41% | - | - |
| Vistra Corp | 2.40% | - | - |
| Hilton Worldwide Holdings Inc | 3.60% | - | - |
| Coupang Inc | 2.75% | - | - |
| Alnylam Pharmaceuticals Inc | 2.39% | - | - |
| Cardinal Health Inc | 2.72% | - | - |